Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.
Compound LB20304 is a fluoronaphthyridone carboxylic acid with a novel pyrrolidine substituent. This drug was compared with ciprofloxacin, levofloxacin, ofloxacin, and trovafloxacin against over 800 pathogens, most from blood stream infections, by National Committee for Clinical Laboratory Standards...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1997
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163688/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8980783/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.1.204 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
